Clover Health Investments, Corp.

NasdaqGS:CLOV Voorraadrapport

Marktkapitalisatie: US$2.1b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Clover Health Investments Toekomstige groei

Future criteriumcontroles 0/6

De omzet van Clover Health Investments zal naar verwachting dalen met 2.4% per jaar, terwijl de jaarlijkse winst naar verwachting zal groeien met 19.8% per jaar. De winst per aandeel zal naar verwachting groeien met 20.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting -16.8% zijn.

Belangrijke informatie

21.4%

Groei van de winst

21.9%

Groei van de winst per aandeel

Healthcare winstgroei19.8%
Inkomstengroei-1.7%
Toekomstig rendement op eigen vermogen-19.9%
Dekking van analisten

Low

Laatst bijgewerkt08 Oct 2024

Recente toekomstige groei-updates

Recent updates

There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Oct 03
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Clover Health: Changing Business Model, Seeking Profitability

Oct 03

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Aug 15

Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Aug 14
Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Aug 06
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jun 12
Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 20
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Mar 16
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Clover Health: Its Luck May Have Ran Out

Feb 26

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Chamath Palihapitiya-linked Clover Health Investments trading near all-time low

Oct 14

Chamath Palihapitiya cuts stake in Clover Health to under 5%

Oct 04

Rethinking My Clover Health Position

Sep 12

Clover Paid The Price Of Its Alleged Lies; Time To Move On

Aug 17

Clover Health Investments to name president Andrew Toy as CEO

Aug 08

Clover Health Is A Buy Ahead Of Earnings

Jul 29

Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2

Jul 15

Is Clover Health A Good Healthcare Sector Stock Pick?

Jun 30

Winst- en omzetgroeiprognoses

NasdaqGS:CLOV - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20261,690-51N/AN/A2
12/31/20251,506-72N/AN/A3
12/31/20241,393-67N/AN/A3
6/30/20242,090-121-178-177N/A
3/31/20242,059-157-170-169N/A
12/31/20232,036-213-116-116N/A
9/30/20232,040-234-183-178N/A
6/30/20232,441-268-63-58N/A
3/31/20232,989-344-155-150N/A
12/31/20223,579-340-291-286N/A
9/30/20223,041-443-76-75N/A
6/30/20222,564-402-222-222N/A
3/31/20222,075-615-247-246N/A
12/31/20211,361-588-283-282N/A
9/30/20211,158-527-263-262N/A
6/30/2021922-487-252-252N/A
3/31/2021721-160-175-174N/A
12/31/2020690-136-119-118N/A
9/30/2020624-89-126-126N/A
6/30/2020572-145-116-116N/A
3/31/2020507-272-163-163N/A
12/31/2019455-364-160-160N/A
12/31/2018281-202-155-153N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat CLOV de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat CLOV de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat CLOV de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van CLOV zal naar verwachting de komende 3 jaar dalen ( -2.4% per jaar).

Hoge groei-inkomsten: De omzet van CLOV zal naar verwachting de komende 3 jaar dalen ( -2.4% per jaar).

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Er wordt voorspeld dat CLOV binnen 3 jaar verliesgevend zal zijn.

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y